SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)

Revenue by Segment

Financials in millions EUR. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Drug Containment Solutions (DCS)	548.01M	518.72M	558.00M	598.92M	492.13M
Drug Delivery Solutions (DDS)	438.76M	438.74M	343.64M	222.86M	157.68M
Consolidation/Reconciliation	-561.00K	-367.00K	-3.03M	-636.00K	-1.14M
Total	986.21M	957.09M	898.60M	821.14M	648.67M

Revenue by Geography

Financials in millions EUR. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
EMEA	638.71M	619.71M	552.34M	423.50M	309.47M
Asia and South Pacific	109.90M	112.74M	101.79M	128.84M	141.91M
North America	151.74M	144.74M	162.47M	180.54M	130.36M
South America	85.86M	79.90M	82.01M	88.27M	66.93M
Total	986.21M	957.09M	898.60M	821.14M	648.67M

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 24, 2026

Data Sources Report a data error